Alfehaid L, Farah S, Omer A, Weber B, Alkhezi O, Tawfik Y
JAMA Netw Open. 2024; 7(9):e2431309.
PMID: 39240567
PMC: 11380098.
DOI: 10.1001/jamanetworkopen.2024.31309.
Dolin R, Shenvi E, Alvarez C, Barrows Jr R, Boxwala A, Lee B
Appl Clin Inform. 2024; 15(2):378-387.
PMID: 38388174
PMC: 11098593.
DOI: 10.1055/a-2274-6763.
Tangsuwanaruk T, Wittayachamnankul B
BMC Pharmacol Toxicol. 2022; 23(1):84.
PMID: 36316720
PMC: 9620625.
DOI: 10.1186/s40360-022-00623-0.
Gupta A, Chauhan S, Gaur A, Parthasarathi R
Struct Chem. 2022; 33(6):2179-2193.
PMID: 36093277
PMC: 9439941.
DOI: 10.1007/s11224-022-02049-0.
Reese T, Wright A, Liu S, Boyce R, Romero A, Del Fiol G
Am J Health Syst Pharm. 2022; 79(13):1086-1095.
PMID: 35136935
PMC: 9218784.
DOI: 10.1093/ajhp/zxac045.
Comparing Potential Drug-Drug Interactions in Companion Animal Medications Using Two Electronic Databases.
Boonyarattanasoonthorn T, Khemawoot P, Kijtawornrat A
Vet Sci. 2021; 8(4).
PMID: 33917796
PMC: 8068153.
DOI: 10.3390/vetsci8040060.
A Minimal Information Model for Potential Drug-Drug Interactions.
Hochheiser H, Jing X, Garcia E, Ayvaz S, Sahay R, Dumontier M
Front Pharmacol. 2021; 11:608068.
PMID: 33762928
PMC: 7982727.
DOI: 10.3389/fphar.2020.608068.
Drug-Drug Interactions in Elderly Patients with Potentially Inappropriate Medications in Primary Care, Nursing Home and Hospital Settings: A Systematic Review and a Preliminary Study.
Bories M, Bouzille G, Cuggia M, Le Corre P
Pharmaceutics. 2021; 13(2).
PMID: 33669162
PMC: 7919637.
DOI: 10.3390/pharmaceutics13020266.
Towards a foundational representation of potential drug-drug interaction knowledge.
Brochhausen M, Schneider J, Malone D, Empey P, Hogan W, Boyce R
CEUR Workshop Proc. 2020; 1309:16-31.
PMID: 33139970
PMC: 7603806.
Prediction of Severity of Drug-Drug Interactions Caused by Enzyme Inhibition and Activation.
Dmitriev A, Filimonov D, Lagunin A, Karasev D, Pogodin P, Rudik A
Molecules. 2019; 24(21).
PMID: 31683720
PMC: 6864873.
DOI: 10.3390/molecules24213955.
Countrywide prevalence of critical drug interactions in Hungarian outpatients: a retrospective analysis of pharmacy dispensing data.
Somogyi-Vegh A, Ludanyi Z, Erdos A, Botz L
BMC Pharmacol Toxicol. 2019; 20(1):36.
PMID: 31151485
PMC: 6544909.
DOI: 10.1186/s40360-019-0311-0.
Effect of training and structured medication review on medication appropriateness in nursing home residents and on cooperation between health care professionals: the InTherAKT study protocol.
Mahlknecht A, Nestler N, Bauer U, Schussler N, Schuler J, Scharer S
BMC Geriatr. 2017; 17(1):24.
PMID: 28100176
PMC: 5241939.
DOI: 10.1186/s12877-017-0418-3.
Chronic Pain: How Challenging Are DDIs in the Analgesic Treatment of Inpatients with Multiple Chronic Conditions?.
Siebenhuener K, Eschmann E, Kienast A, Schneider D, Minder C, Saller R
PLoS One. 2017; 12(1):e0168987.
PMID: 28046033
PMC: 5207693.
DOI: 10.1371/journal.pone.0168987.
A comparison of five common drug-drug interaction software programs regarding accuracy and comprehensiveness.
Kheshti R, Aalipour M, Namazi S
J Res Pharm Pract. 2016; 5(4):257-263.
PMID: 27843962
PMC: 5084483.
DOI: 10.4103/2279-042X.192461.
Developing strategies for predicting hyperkalemia in potassium-increasing drug-drug interactions.
Eschmann E, Beeler P, Schneemann M, Blaser J
J Am Med Inform Assoc. 2016; 24(1):60-66.
PMID: 27174894
PMC: 7654079.
DOI: 10.1093/jamia/ocw050.
Recommendations for selecting drug-drug interactions for clinical decision support.
Tilson H, Hines L, McEvoy G, Weinstein D, Hansten P, Matuszewski K
Am J Health Syst Pharm. 2016; 73(8):576-85.
PMID: 27045070
PMC: 5064943.
DOI: 10.2146/ajhp150565.
Electrochemical Synthesis and Kinetic Evaluation of Electrooxidation of Acetaminophen in the Presence of Antidepressant Drugs.
Nematollahi D, Feyzi Barnaji B, Amani A
Iran J Pharm Res. 2015; 14(4):1115-22.
PMID: 26664378
PMC: 4673939.
Recommendations to improve the usability of drug-drug interaction clinical decision support alerts.
Payne T, Hines L, Chan R, Hartman S, Kapusnik-Uner J, Russ A
J Am Med Inform Assoc. 2015; 22(6):1243-50.
PMID: 25829460
PMC: 11737836.
DOI: 10.1093/jamia/ocv011.
Consensus recommendations for systematic evaluation of drug-drug interaction evidence for clinical decision support.
Scheife R, Hines L, Boyce R, Chung S, Momper J, Sommer C
Drug Saf. 2015; 38(2):197-206.
PMID: 25556085
PMC: 4624322.
DOI: 10.1007/s40264-014-0262-8.
Drug interaction alert override rates in the Meaningful Use era: no evidence of progress.
Bryant A, Fletcher G, Payne T
Appl Clin Inform. 2014; 5(3):802-13.
PMID: 25298818
PMC: 4187095.
DOI: 10.4338/ACI-2013-12-RA-0103.
